Clinical trial risk in type-2 diabetes: importance of patient history.

Purpose: To determine the risk of clinical trial failure for drugs developed for type-2 diabetes.

Methods: Drugs were investigated by reviewing phase I to phase III studies that were conducted between 1998 and February 2013. The clinical trial success rates were calculated and compared to the industry standard.